ArticleIndian journal of dermatology
Is Impaired Sleep Quality a Triggering Factor in Melasma Patients? A Cross-Sectional Study.
Article in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sleep disorders trigger the hormonal imbalance and the accumulation of reactive oxygen molecules which are involved in melasma pathogenesis. Aims and Objectives: This study aims to assess the potential relationship between melasma and sleep components. Material and Methods: One hundred patients with melasma and 100 sex- and age-matched healthy controls aged over 18 were included. The melasma area severity index (MASI) and melasma quality of life (MelasQoL) scores of the patients were calculated. The Pittsburg Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS) were applied to patients with melasma and healthy controls. Results: Compared with the controls, the median PSQI and ESS total scores were higher in the melasma patients. The patients with melasma reported impaired sleep components more frequently than the healthy controls. The rate of cases with excessive daytime sleepiness was similar between the patients and the controls. The analysis did not reveal any statistically significant correlation between MASI, MelasQoL, and the two questionnaires for melasma patients. In the multivariate analyses, the following factors were found to affect melasma: subjective sleep quality score (OR: 2.49, 95%CI: 1.26-4.89); sleep latency score (OR: 2.16, 95%CI: 1.34-3.49), sleep disturbances score (OR: 2.78, 95%CI: 1.17-6.57), Fitzpatrick skin type (OR: 1.88, 95% CI: 1.15-3.07), and total ESS score (OR: 1.13, 95% CI: 1.04-1.23). Conclusion: Our study's findings suggest impaired subjective sleep quality, prolonged sleep onset latency, and sleep disturbances may affect melasma. Dermatologists should consider the potential benefits of improving sleep hygiene and treating sleep disorders in melasma patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.